Because AOD 9604 focuses on lipolysis (fat burning) rather than just rapid weight loss through calorie restriction, it is often touted as a way to help maintain muscle while losing fat
Injectable and microneedling-assisted delivery produce earlier visible results than topical-only protocols due to 10 to 20x higher bioavailability at follicle depth
The disadvantage is losing the synergistic healing support from BPC-157 and TB-500
Understanding BPC-157 Micro-Dosing The Science Behind Lower Doses Chronic Conditions That Respond Well Micro-Dosing vs Standard Protocols Optimal Micro-Dosing Protocols Injectable Administration Techniques Combining with Other Therapies Timeline and What to Expect Cycling Strategies for Long-Term Use Quality and Sourcing Considerations Frequently Asked Questions Glossary of Terms References Understanding BPC-157 Micro-Dosing BPC-157 stands for Body Protection Compound 157, a synthetic peptide containing 15 amino acids derived from a protective protein naturally found in human gastric juice
What Animal and Cell Models Cannot Prove Animal and cell models can show biological signals, dose-response patterns, and mechanistic hypotheses, but they cannot prove that a peptide produces the same benefit in people
PMID: 17672515 | doi:10.1021/tx700185s Mazurowska L et al